CTOs on the Move

MSI

www.methylationsciences.com

 
MSI Methylation Sciences Inc. (“MSI”) is a clinical-stage pharmaceutical company focused on developing new products based on molecules which have clinical proof of concept but which have yet to be exploited in the major pharmaceutical markets. MSI`s focus is in the CNS space where clinical proof of concept is key to reducing the drug development risk. Our lead product candidate, Strada™, is based upon Ademetionine, a naturally occurring molecule produced throughout the body, where it plays a vital role in the one-carbon cycle. Our disease indication is Major Depressive Disorder (MDD).
  • Number of Employees: 0-25
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details

Funding

MSI raised $30M on 10/07/2016

Similar Companies

Omnica Corporation

Omnica Corporation is a Irvine, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

AHRI

AHRI is a Birmingham, AL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Educational Resource Systems

Educational Resource Systems is a Red Bank, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

IOA Healthcare Furniture

IOA is committed to providing solutions that improve healthcare spaces. We listen to our customers in order to design, develop and engineer innovations that meet unfulfilled needs while inspiring great Design. A family-owned company, the Delmestri family has been manufacturing furniture for four generations. The company was founded in Udine, Northern Italy in 1924, and was known as a leading manufacturer of contemporary seating designs.

MedeAnalytics

MedeAnalytics provides evidence-based insights to solve a real problem that plagues health care – how to use the immense amount of patient data collected along the care continuum to deliver cost – effective care and promote a healthier population. The platform delivers intelligence that helps healthcare organizations detect their greatest areas of risk and identify opportunities to improve their financial health. It empowers providers and health plans to collaborate and use data to strengthen their operations and improve the quality of care. MedeAnalytics` cloud-based tools have been used to analyze more than 21 billion patient encounters in the United States and United Kingdom, providing better care to more than 30 million patients and better business for 900 healthcare organizations.